Combining Chinese and Western medicine could lead to new cancer treatments

Combining traditional forms of Chinese and Western medicine could offer new hope for developing new treatments for liver, lung, colorectal cancers and osteosarcoma of the bones.

Experts from Cardiff University's School of Medicine have joined forces with Peking University in China to test the health benefits of a traditional Chinese medicine.

The team also set-out to examine how by combining it with more traditional methods like Chemotherapy could improve patient outcomes and potentially lead to the development of new cancer treatments and therapies.

"Traditional Chinese medicine where compounds are extracted from natural products or herbs has been practised for centuries in China, Korea, Japan and other countries in Asia," according to Professor Wen Jiang from Cardiff University's School of Medicine, who is the director of the Cardiff University-Peking University Joint Cancer Institute at Cardiff and led the research as part of a collaboration between Cardiff University and Peking University.

"Although a few successes, most of the traditional remedies are short of which has inevitably led to scepticism – especially amongst traditionalists in the West.

"As a result, we set out to test the success of a Chinese medicine and then consider how combining it alongside traditional methods like Chemotherapy could result in positive outcome for patients," he adds.

Yangzheng Xiaoji is a traditional Chinese formula consisting of 14 herbs. The formula has been shown to be beneficial to – however, until now how it works has remained unknown.

Since 2012 the Team have investigated how the formula works, discovering that it works by blocking a pathway which stops the spread of in the body.

"The formula has been shown to be beneficial to patients with certain solid tumours, when used alone and in conventional therapies, such as Chemotherapy.

"It suggests that combining the formula with conventional as well as new therapies could hold the key to developing new treatments for cancer patients.

"We are already looking to clinical trials in treatment of lung and other cancer types."

Funded by Cancer Research Wales and the Albert Hung Foundation – the results will be presented at the European Cancer Congress 2013 which takes place in Amsterdam between the 27th September and 1st October.

add to favorites email to friend print save as pdf

Related Stories

New marker identified for early diagnosis of lung cancer

Sep 17, 2013

A protein called isocitrate dehydrogenase (IDH1) is present at high levels in lung cancers and can be detected in the blood, making it a noninvasive diagnostic marker for lung cancers, according to a study published in Clinical Ca ...

'Wildly heterogeneous genes'

Sep 15, 2013

Cancer tumors almost never share the exact same genetic mutations, a fact that has confounded scientific efforts to better categorize cancer types and develop more targeted, effective treatments.

Recommended for you

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.